686 related articles for article (PubMed ID: 33789145)
1. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
Tahmasebi S; Saeed BQ; Temirgalieva E; Yumashev AV; El-Esawi MA; Navashenaq JG; Valizadeh H; Sadeghi A; Aslani S; Yousefi M; Jadidi-Niaragh F; Adigozalou J; Ahmadi M; Roshangar L
Life Sci; 2021 Jul; 276():119437. PubMed ID: 33789145
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
Tahmasebi S; El-Esawi MA; Mahmoud ZH; Timoshin A; Valizadeh H; Roshangar L; Varshoch M; Vaez A; Aslani S; Navashenaq JG; Aghebati-Maleki L; Ahmadi M
J Cell Physiol; 2021 Jul; 236(7):5325-5338. PubMed ID: 33372280
[TBL] [Abstract][Full Text] [Related]
3. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial.
Ahmadi M; Hajialilo M; Dolati S; Eghbal-Fard S; Heydarlou H; Ghaebi M; Ghassembaglou A; Aghebati-Maleki L; Samadi Kafil H; Kamrani A; Rahnama B; Rikhtegar R; Yousefi M
J Cell Biochem; 2020 Jan; 121(1):103-110. PubMed ID: 31074089
[TBL] [Abstract][Full Text] [Related]
4. Nanocurcumin supplementation ameliorates Behcet's disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial.
Abbasian S; Soltani-Zangbar MS; Khabbazi A; Farzaneh R; Malek Mahdavi A; Motavalli R; Hajialilo M; Yousefi M
Int Immunopharmacol; 2021 Dec; 101(Pt B):108237. PubMed ID: 34653732
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study.
Soltani-Zangbar MS; Hajivalili M; Daneshdoust D; Ghadir S; Savari G; Zolfaghari M; Aghebati-Maleki L; Oloufi S; Nouri N; Amini N; Mehdizadeh A; Ghasemi Moghadam H; Mahmoodpoor A; Ahmadian Heris J; Yousefi M
Cytokine; 2023 Sep; 169():156248. PubMed ID: 37307689
[TBL] [Abstract][Full Text] [Related]
6. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
Sadeghi A; Tahmasebi S; Mahmood A; Kuznetsova M; Valizadeh H; Taghizadieh A; Nazemiyeh M; Aghebati-Maleki L; Jadidi-Niaragh F; Abbaspour-Aghdam S; Roshangar L; Mikaeili H; Ahmadi M
J Cell Physiol; 2021 Apr; 236(4):2829-2839. PubMed ID: 32926425
[TBL] [Abstract][Full Text] [Related]
7. Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis.
Dolati S; Babaloo Z; Ayromlou H; Ahmadi M; Rikhtegar R; Rostamzadeh D; Roshangar L; Nouri M; Mehdizadeh A; Younesi V; Yousefi M
J Neuroimmunol; 2019 Feb; 327():15-21. PubMed ID: 30683426
[TBL] [Abstract][Full Text] [Related]
8. Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions.
Ahmad Merza Mohammad T
Hum Immunol; 2023 Sep; 84(9):471-483. PubMed ID: 37331910
[TBL] [Abstract][Full Text] [Related]
9. Impaired balance of Th17/Treg in patients with nasal polyposis.
Shen Y; Tang XY; Yang YC; Ke X; Kou W; Pan CK; Hong SL
Scand J Immunol; 2011 Aug; 74(2):176-85. PubMed ID: 21375554
[TBL] [Abstract][Full Text] [Related]
10. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
[TBL] [Abstract][Full Text] [Related]
11. The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.
Hassaniazad M; Inchehsablagh BR; Kamali H; Tousi A; Eftekhar E; Jaafari MR; Fathalipour M; Nikoofal-Sahlabadi S; Gouklani H; Alizade H; Nikpoor AR
Trials; 2020 Oct; 21(1):876. PubMed ID: 33092653
[TBL] [Abstract][Full Text] [Related]
12. Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells.
Liu H; Ji Y; Ma X; He A; Zhao W; Zhang P; Gu L; Lei B; Zhang Y; Wang Y; Zhang W; Wang J
Mol Immunol; 2021 Apr; 132():199-208. PubMed ID: 33454107
[TBL] [Abstract][Full Text] [Related]
13. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
Shao TY; Hsu LH; Chien CH; Chiang BL
Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.
Xu F; Yu S; Qin M; Mao Y; Jin L; Che N; Liu S; Ge R
Inflammation; 2018 Feb; 41(1):81-92. PubMed ID: 28894978
[TBL] [Abstract][Full Text] [Related]
15. Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis.
Dolati S; Ahmadi M; Rikhtegar R; Babaloo Z; Ayromlou H; Aghebati-Maleki L; Nouri M; Yousefi M
Int Immunopharmacol; 2018 Aug; 61():74-81. PubMed ID: 29852475
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
17. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.
Liang XS; Li CZ; Zhou Y; Yin W; Liu YY; Fan WH
World J Gastroenterol; 2014 Jul; 20(26):8558-71. PubMed ID: 25024610
[TBL] [Abstract][Full Text] [Related]
18. The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome.
Ye J; Liu H; Zhang G; Li P; Wang Z; Huang S; Yang Q; Li Y
Mediators Inflamm; 2012; 2012():815308. PubMed ID: 23345934
[TBL] [Abstract][Full Text] [Related]
19. Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules.
Haddadi MH; Negahdari B; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Dabiri H; Baharvand H
Clin Exp Immunol; 2020 Aug; 201(2):205-221. PubMed ID: 32403163
[TBL] [Abstract][Full Text] [Related]
20. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats.
Long Y; Li S; Qin J; Xie L; Gan L; Jie F; Wu Y; Li Y; Du Q
Biomed Pharmacother; 2018 Sep; 105():781-788. PubMed ID: 29909346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
